StonvexLoading…
StonvexStonvexStonvexCore line items from ATRA's most recent SEC filings (10-K / 10-Q via EDGAR XBRL). Last 4 reporting periods.
Quarterly filings sourced directly from SEC EDGAR. Real-time earnings actuals are in the Earnings panel above.
| Metric | Annual 2025 2025-12-31 | Annual 2024 2024-12-31 | Annual 2023 2023-12-31 | Annual 2022 2022-12-31 |
|---|---|---|---|---|
Revenue | $120.77M | $128.94M | $8.57M | $63.57M |
Operating Income | $35.86M | $-83.44M | $-276.01M | $-280.51M |
Net Income | $32.69M | $-85.40M | $-276.13M | $-228.30M |
EPS (Diluted) | $2.57 | $-11.41 | $-65.19 | $-2.24 |
Total Assets | $20.23M | $109.10M | $165.50M | $376.42M |
Total Liabilities | $58.74M | $206.38M | $264.74M | $249.78M |
Cash & Equivalents | $8.48M | $25.03M | $25.84M | $92.94M |
Free Cash Flow OCF − CapEx | $-50.94M | $-68.96M | $-194.20M | $-274.62M |
Shares Outstanding | 7.32M | 5.86M | 4.26M | 95.93M |